製品の概要

  • 製品名Anti-MYO6 antibody [MUD-19]
    MYO6 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal [MUD-19] to MYO6
  • アプリケーション適用あり: ELISA, WBmore details
  • 種交差性
    交差種: Mouse, Rat, Human
  • 免疫原

    Synthetic peptide, corresponding to amino acids 291-302 of Human MYO6.

  • ポジティブ・コントロール
    • A431 whole cell lysate.

製品の特性

  • 製品の状態Liquid
  • 保存方法Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
  • バッファーPreservative: 15mM Sodium Azide
    Constituents: 1% BSA, 0.01M PBS, pH 7.4
  • Concentration information loading...
  • 精製度Protein A purified
  • ポリ/モノモノクローナル
  • クローン名MUD-19
  • アイソタイプIgG1
  • 研究分野

関連製品

アプリケーション

Our Abpromise guarantee covers the use of ab11095 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ELISA Use at an assay dependent concentration.
WB Use a concentration of 2 µg/ml. Detects a band of approximately 150 kDa.

ターゲット情報

  • 機能Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Myosin 6 is a reverse-direction motor protein that moves towards the minus-end of actin filaments. Has slow rate of actin-activated ADP release due to weak ATP binding. Functions in a variety of intracellular processes such as vesicular membrane trafficking and cell migration. Required for the structural integrity of the Golgi apparatus via the p53-dependent pro-survival pathway. Appears to be involved in a very early step of clathrin-mediated endocytosis in polarized epithelial cells. May act as a regulator of F-actin dynamics. May play a role in transporting DAB2 from the plasma membrane to specific cellular targets. Required for structural integrity of inner ear hair cells.
  • 組織特異性Expressed in most tissues examined including heart, brain, placenta, pancreas, spleen, thymus, prostate, testis, ovary, small intestine and colon. Highest levels in brain, pancreas, testis and small intestine. Also expressed in fetal brain and cochlea. Isoform 1 and isoform 2, containing the small insert, and isoform 4, containing neither insert, are expressed in unpolarized epithelial cells.
  • 関連疾患Defects in MYO6 are the cause of deafness autosomal dominant type 22 (DFNA22) [MIM:606346]. DFNA22 is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA22 is progressive and postlingual, with onset during childhood. By the age of approximately 50 years, affected individuals invariably have profound sensorineural deafness.
    Defects in MYO6 are the cause of deafness autosomal recessive type 37 (DFNB37) [MIM:607821].
    Defects in MYO6 are the cause of deafness sensorineural with hypertrophic cardiomyopathy (DFNHCM) [MIM:606346].
  • 配列類似性Contains 1 IQ domain.
    Contains 1 myosin head-like domain.
  • ドメインDivided into three regions: a N-terminal motor (head) domain, followed by a neck domain consisting of a calmodulin-binding linker domain and a single IQ motif, and a C-terminal tail region with a coiled-coil and a unique globular domain required for interaction with other proteins.
  • 翻訳後修飾Phosphorylation in the motor domain, induced by EGF, results in translocation of MYO6 from the cell surface to membrane ruffles and affects F-actin dynamics. Phosphorylated in vitro by p21-activated kinase (PAK).
  • 細胞内局在Cytoplasmic vesicle > clathrin-coated vesicle membrane; Cytoplasmic vesicle > clathrin-coated vesicle membrane. Cell projection > ruffle membrane and Golgi apparatus > trans-Golgi network membrane. Golgi apparatus. Nucleus. Cytoplasm > perinuclear region. Membrane > clathrin-coated pit. Cell projection > ruffle membrane. Also present in endocyctic vesicles, and membrane ruffles. Translocates from membrane ruffles, endocytic vesicles and cytoplasm to Golgi apparatus, perinuclear membrane and nucleus through induction by p53 and p53-induced DNA damage. Recruited into membrane ruffles from cell surface by EGF-stimulation. Colocalizes with DAB2 in clathrin-coated pits/vesicles. Colocalizes with OPTN at the Golgi complex and in vesicular structures close to the plasma membrane.
  • Information by UniProt
  • 参照データベース
  • 別名
    • Deafness autosomal recessive 37 antibody
    • DFNA 22 antibody
    • DFNA22 antibody
    • DFNB 37 antibody
    • DFNB37 antibody
    • KIAA0389 antibody
    • MYO 6 antibody
    • Myo6 antibody
    • MYO6_HUMAN antibody
    • Myosin VI antibody
    • Myosin-VI antibody
    • Myosin6 antibody
    • Unconventional myosin-6 antibody
    • Unconventional myosin-VI antibody
    see all

Anti-MYO6 antibody [MUD-19] 画像

  • All lanes : Anti-MYO6 antibody [MUD-19] (ab11095) at 1/250 dilution

    Lane 1 : Whole cell lysate prepared from human breast cell lines
    Lane 2 : Whole cell lysate prepared from human breast cell lines
    Lane 3 : Whole cell lysate prepared from human breast cell lines
    Lane 4 : Whole cell lysate prepared from human breast cell lines

    Secondary
    Rabbit anti-mouse conjugated to HRP
    Developed using the ECL technique

    Exposure time : 10 seconds

    Image courtesy of Dr Damian Yap by Abreview.

Anti-MYO6 antibody [MUD-19] (ab11095) 使用論文

ab11095 has not yet been referenced specifically in any publications.

Product Wall

Abcam guarantees this product to work in the species/application used in this Abreview.
Application Western blot
Sample Human Cell lysate - whole cell (Human breast cell lines)
Loading amount 10 µg
Specification Human breast cell lines
Gel Running Conditions Reduced Denaturing
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 20°C
Username

Dr. Damian Yap

Verified customer

投稿 Apr 21 2011

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"